Journey Medical (DERM) Receivables - Net (2020 - 2025)
Historic Receivables - Net for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $18.0 million.
- Journey Medical's Receivables - Net rose 6852.22% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 6852.22%. This contributed to the annual value of $10.2 million for FY2024, which is 3278.81% down from last year.
- Per Journey Medical's latest filing, its Receivables - Net stood at $18.0 million for Q3 2025, which was up 6852.22% from $15.6 million recorded in Q2 2025.
- Over the past 5 years, Journey Medical's Receivables - Net peaked at $31.7 million during Q3 2021, and registered a low of $8.0 million during Q3 2023.
- Moreover, its 5-year median value for Receivables - Net was $18.0 million (2025), whereas its average is $19.5 million.
- Per our database at Business Quant, Journey Medical's Receivables - Net plummeted by 7200.08% in 2023 and then surged by 8394.73% in 2025.
- Over the past 5 years, Journey Medical's Receivables - Net (Quarter) stood at $23.1 million in 2021, then grew by 22.05% to $28.2 million in 2022, then plummeted by 46.04% to $15.2 million in 2023, then crashed by 32.79% to $10.2 million in 2024, then soared by 75.77% to $18.0 million in 2025.
- Its Receivables - Net was $18.0 million in Q3 2025, compared to $15.6 million in Q2 2025 and $18.0 million in Q1 2025.